|
| 37139596 | Germline loss-of-function <i>BRCA1</i> and <i>BRCA2</i> mutations and risk of <i>de novo</i> hematopoietic malignancies. | Haematologica | 2024 |
| 36322930 | Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. | Blood | 2023 |
| 37590029 | Germ line risk variants: beyond cancer. | Blood | 2023 |
| 37421681 | Germline predisposition to clonal hematopoiesis. | Leuk Res | 2023 |
| 37406166 | Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. | Blood Adv | 2023 |
| 37405177 | Systemic mastocytosis, in the context of a deleterious germline <i>SDHC</i> variant, treated with ripretinib. | JAAD Case Rep | 2023 |
| 36655425 | Clinical and molecular response of acute myeloid leukemia harboring non-canonical <i>FLT3</i> N676K driver mutations to contemporary FLT3 inhibitors. | Haematologica | 2023 |
| 36847506 | (R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers. | Cancer Discov | 2023 |
| 36809258 | Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks. | J Clin Invest | 2023 |
| 36455200 | DDX41-associated susceptibility to myeloid neoplasms. | Blood | 2023 |
| 36793609 | Prioritization of patients for germline testing based on tumor profiling of hematopoietic malignancies. | Front Oncol | 2023 |
| 36453641 | Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones. | Blood Adv | 2023 |
| 36001442 | Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies. | Blood Adv | 2023 |
| 35063349 | A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias. | Genet Med | 2022 |
| 35674998 | Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies. | Curr Hematol Malig Rep | 2022 |
| 35767897 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. | Blood | 2022 |
| 35797463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 |
| 35764482 | Revision of RUNX1 variant curation rules. | Blood Adv | 2022 |
| 35419889 | Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. | Hum Mutat | 2022 |
| 35969835 | Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages. | Blood | 2022 |
| 36138229 | Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation. | Nat Genet | 2022 |
| 36271151 | Classification of rare pediatric myeloid neoplasia-Quo vadis? | Leukemia | 2022 |
| 36130297 | Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. | Blood | 2022 |
| 36266327 | Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia. | Leukemia | 2022 |
| 35942521 | MYCN and HIF-1 directly regulate <i>TET1</i> expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia. | Epigenetics | 2022 |
| 32286542 | Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome. | Leukemia | 2021 |
| 35844676 | Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adults. | EJHaem | 2021 |
| 33850299 | Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer. | Leukemia | 2021 |
| 33510405 | Germline variants drive myelodysplastic syndrome in young adults. | Leukemia | 2021 |
| 33615436 | Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities. | Br J Haematol | 2021 |
| 34994594 | Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology. | JCO Precis Oncol | 2021 |
| 34435481 | BET inhibitors enhance embryonic and fetal <i>globin</i> expression in erythroleukemia cell lines. | Haematologica | 2021 |
| 34405775 | Anticipation in hematopoietic malignancies: biology, bias, or both? | Leuk Lymphoma | 2021 |
| 34492705 | Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy. | Blood Adv | 2021 |
| 34753908 | The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. | Nat Commun | 2021 |
| 34019812 | Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. | Stem Cell Reports | 2021 |
| 34155975 | Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites. | Elife | 2021 |
| 34298596 | Genetics of Myelodysplastic Syndromes. | Cancers (Basel) | 2021 |
| 34100074 | Germline predisposition to hematopoietic malignancies. | Hum Mol Genet | 2021 |
| 33980986 | RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function. | J Hum Genet | 2021 |
| 34233450 | The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy. | Haematologica | 2021 |
| 34028844 | Clinical features and survival outcomes in patients with chronic myelomonocytic leukemia arising in the context of germline predisposition syndromes. | Am J Hematol | 2021 |
| 33394724 | Germline mutations in MDS/AML predisposition disorders. | Curr Opin Hematol | 2021 |
| 32807974 | Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies. | Genet Med | 2021 |
| 32165484 | How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for <i>RUNX1</i> variant curation for germline predisposition to myeloid malignancies. | Haematologica | 2020 |
| 31647332 | Correct application of variant classification guidelines in germline <i>RUNX1</i> mutated disorders to assist clinical diagnosis. | Leuk Lymphoma | 2020 |
| 32101699 | MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome. | Cell Chem Biol | 2020 |
| 32074275 | A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. | Blood Adv | 2020 |
| 31852832 | 5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma. | Clin Cancer Res | 2020 |
| 33108454 | Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies. | Blood Adv | 2020 |